Levels of two other glycolytic enzymes, fructose-bisphosphate aldolase A (ALDOA) and pyruvate kinase (PKM), have recently been shown to be elevated in cerebrospinal fluid (CSF) of AD patients, forming part of a six-protein AD signature (Li et al, 2023). This evidence concerns the gene PKM and Alzheimer disease.